November 5, 2007Open Access
Ver artículo completoRosuvastatin in Older Patients with Systolic Heart Failure
PICO estructurado
Does rosuvastatin reduce the primary outcome in older patients with systolic heart failure?
P
Población
Older patients with systolic heart failure
I
Intervención
Rosuvastatin
Rosuvastatin does not reduce the primary outcome or all-cause mortality in older patients with systolic heart failure, but it reduces cardiovascular hospitalizations.
Resumen
Rosuvastatin did not reduce the primary outcome or the number of deaths from any cause in older patients with systolic heart failure, although the drug did reduce the number of cardiovascular hospitalizations. The drug did not cause safety problems. (ClinicalTrials.gov number, NCT00206310.)
Cite This Study
Kjekshus et al. (Mon,) studied this question.